(Q38318751)

2 September 2017

title

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial (English)

1 reference

2 September 2017

0 references

7

E J Orav

1 reference

2 September 2017

M J Mann

1

1 reference

2 September 2017

A D Whittemore

2

1 reference

2 September 2017

M C Donaldson

3

1 reference

2 September 2017

M Belkin

4

1 reference

2 September 2017

M S Conte

5

1 reference

2 September 2017

J F Polak

6

1 reference

2 September 2017

A Ehsan

8

1 reference

2 September 2017

G Dell'Acqua

9

1 reference

2 September 2017

V J Dzau

10

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

2 September 2017

number of pages

6

1 reference

inferred from page(s)

published in

The Lancet

1 reference

2 September 2017

volume

354

1 reference

2 September 2017

issue

9189

1 reference

2 September 2017

page(s)

1493-1498

1 reference

The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Human saphenous vein grafts explanted from the arterial circulation demonstrate altered smooth-muscle and endothelial responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Functional abnormalities of experimental autogenous vein graft neoendothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Genetic engineering of vein grafts resistant to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Intensive surveillance of femoropopliteal-tibial autogenous vein bypasses improves long-term graft patency and limb salvage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

AT1 and AT2 angiotensin receptor gene expression in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Cell cycle progression: new therapeutic target for vascular proliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

Arterial structural changes with verapamil in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2909405-2

7 January 2021

10.1016/S0140-6736(99)09405-2

Identifiers

DOI

1 reference

release_24o3lntzrbhzdgrzofglmk476e

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/24o3lntzrbhzdgrzofglmk476e

24 November 2022

mapped directly with Wikidata item

1 reference